Is your approach to label management letting you down? - Verdict Medical Devices
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Is your approach to label management letting you down?

22 Jun 2021

Sponsored by Kallik Sponsored by Visit Company
Is your approach to label management letting you down?

Medical device companies are under a lot of pressure to design top-quality products that comply with a range of regulatory needs requirements while performing reliably. This focus on the device itself is so strong, that many companies end up underestimating the importance of other aspects of product development.

Label management is one area where, if overlooked, significant delays, inefficiencies and problems may arise.

With the deadline for the new EU Medical Device Regulation (MDR) just recently past, many companies may have learned this the hard way. MDR brings added complexity to labelling processes by enforcing unique device identification (UDI) information on all labels.

The aftermath of cases such as the PIP Breast Implant Scandal, where health bodies struggled to trace who had received unsafe silicone implants, paved the way for the

As manufacturers scrambled to redesign each of their labels under the new requirements, those with inefficient processes were encountering problems. For many, a disjointed approach is at the root of the problem.

From legal and regulatory departments to marketing, trademark and product design, many teams contribute to label creation. Using traditional systems, one person is often left trying to piece it all together, searching through a range of emails and documents from different sources in an attempt to understand whether they have the correct or latest version.

With such a fragmented approach, it’s easy to see how errors can arise. However, when it comes to pharmaceutical and medical device products, there is no room for getting it wrong.

According to Dave Tarbuck, vice president of global customer excellence at label and artwork management specialists Kallik, the consequences can be both financial and fatal.

A lot at stake

“If you’ve got a drug and the packaging or instructions say to take it 23 times a day instead of two to three times, that product has to be recalled because the information is wrong. That error can cost millions and millions of pounds, not to mention create significant reputational damage,” says Tarbuck.

The implant scandal is just one example of this. FDA figures reveal that there has been a large increase in product recalls in the last decade, 15% of which are attributable to labelling errors.

Situations like this are the worst-case scenario. But, by lacking an effective label management system, medical device companies may be suffering in other ways.

“Many medical device companies experience geographical challenges when they have sites across the globe,” says Tarbuck. “They don’t have the level of control they need over both their labelling and their content. Additionally, they have a high level of risk of things being done incorrectly. That means that if something is inaccurate, they struggle to pinpoint where it went wrong in the process. Software like Veraciti centralises all of that.”

How Veraciti can help

Veraciti, Kallik’s cloud-based platform stores and manages each component of the label’s artwork and content, enabling automated artwork generation from a library of assets and phrases. Veraciti simplifies review and approval processes, too, which can be cumbersome over email. Imagine ten different reviewers, making amends on ten different versions of that artwork. You soon lose control.

“With Veraciti, there’s one version of the artwork that everyone looks at. Straightaway, you’re reducing the risk of having out-of-date files sent for review, people commenting on an old version, and everything else that confuses and slows down the process,” explains Tarbuck.

In today’s climate, speeding up supply chains has never been more important to the medical industry. Just think back to last year’s sanitiser shortage. “An unfortunate consequence of Covid was the need for companies to consider how their supply chain works and how to shorten timeframes,” says Tarbuck. “Because our system allows people to collaborate, it means supply chains can actually be expedited. The labelling is already there.”

Veraciti has also been instrumental in helping companies meet MDR’s new labelling requirements on time. According to Tarbuck, one Kallik customer had to rework 90,000 labels for their first Class I product. Veraciti was heavily relied upon in the process and, without the system, the client was unlikely to meet the deadline.

However, it’s not just about speed. Veraciti also plays a big role in ensuring label compliance and offering comprehensive audit trails. “It doesn’t matter where you are geographically, you can go to the system to find out who, what, where, when. Because everything is in one place, you are reducing the risk, removing some of the geographical barriers, and speeding up the process as well.”

To find out more on Kallik and the Veraciti software, visit

Free Whitepaper

Six key steps medical device manufacturers must take to successfully navigate the digital maturity curve

With legislation, regulation, branding changes and the normal rigours of product design, development and testing, medical device manufacturers face constant and mounting pressure on their bottom line and their operational efficiency. In Europe alone, there are three major upcoming regulatory changes this year.

The only way companies will weather this storm and stay ahead of the competition is by embracing the benefits of digital transformation – including label and artwork management – so critical to end user safety and regulatory compliance.

Label and artwork management firm Kallik has gathered the lessons learned from the pandemic and beyond to give medical device creators to embracing digital changes and ultimately making life – and the bottom line – more safe and secure.

By clicking the “Submit” button above, you accept and acknowledge that your data will be used as described in the Kallik Privacy Policy.

We will also collect and use the information you provide for carefully considered and specific purposes, where we believe we have a legitimate interest in doing so, for example to send you communications about similar products and services we offer. We will always give you an option to opt out of any future communications from us. You can find out more about our legitimate interest activity in our privacy policy here. ‘We’ includes Verdict Media Limited and other GlobalData brands as detailed here.